Close X
Thursday, October 3, 2024
ADVT 
National

Spending tied to COVID-19 set to drop sharply: PBO

Darpan News Desk The Canadian Press, 10 Mar, 2021 05:52 PM
  • Spending tied to COVID-19 set to drop sharply: PBO

Parliament's budget watchdog says the portion of federal spending related to COVID-19 is set to drop by 86 per cent in the coming fiscal year compared to 2020-21, as Canada transitions away from emergency pandemic measures.

The government is planning $22.7 billion in COVID-19-related spending over the coming year, versus an estimated $159.5 billion to date, according to a new report from parliamentary budget officer Yves Giroux.

Part of the decline relates to a projected plunge in relief spending for individuals.

In 2020-21, an estimated $122 billion flowed to Canadians via labour market supports such as the emergency response benefit, the recovery benefit and enhanced employment insurance, the report states.

The comparable figure for 2021-22 is less than $43 billion, reflecting a gradual phaseout of aid measures.

The report is based on estimates tabled in Parliament last month and does not factor in the coming budget, which may not be introduced until April.

Of the $342.2 billion outlined in the 2021-22 estimates, roughly one in every five dollars is earmarked for monthly payments to Canadian seniors, amounting to $62.4 billion in elder benefits. The benefits are indexed to inflation.

The Canada Health Transfer, indexed to GDP growth, comprises the second-largest component of federal spending, amounting to $43.1 billion to help provinces and territories to help pay for health care.

Parliament must approve government spending through a process called the estimates, with the main estimates — brought forward on Feb. 27 — providing base funding for all departments.

The estimates show the Finance Department budget is slated to shrink by 13 per cent to $103.8 billion and the budget for Employment and Social Development Canada by more than half to $82.4 billion. Public Health Agency of Canada budget is estimated at $8.8 billion, down $21 billion last year.

Of the $342.2 billion outlined in the estimates, $141.9 billion requires House of Commons approval via a pair of appropriation bills.

MORE National ARTICLES

WE Charity registers as federal lobbyist

WE Charity registers as federal lobbyist
WE Charity registered Thursday as a lobbyist of the federal government — months after it began talks with federal officials about potential programs to help Canadian youths during the COVID-19 pandemic.

WE Charity registers as federal lobbyist

Landlords can evict in B.C., but no rent hike

Landlords can evict in B.C., but no rent hike
A payment plan has been set out for renters in British Columbia who haven't been able to pay rent during the COVID-19 pandemic as a government moratorium on evictions ends on Sept. 1.

Landlords can evict in B.C., but no rent hike

B.C. orders publication of wholesale gas prices

B.C. orders publication of wholesale gas prices
Mandatory reporting requirements are being imposed on wholesale gasoline and diesel fuel suppliers in British Columbia to ensure transparency and accountability on pricing.

B.C. orders publication of wholesale gas prices

Actor Ryan Reynolds issues B.C. COVID response

Actor Ryan Reynolds issues B.C. COVID response
Canadian actor Ryan Reynolds has responded to a plea from British Columbia Premier John Horgan for help with messaging to younger residents about partying during a pandemic.

Actor Ryan Reynolds issues B.C. COVID response

Surrey man found guilty of second degree murder in partner Rama Gauravarapu's death

Surrey man found guilty of second degree murder in partner Rama Gauravarapu's death
A property manager, Rama Gauravarapu was murdered at a hotel in West Kelowna two years ago on July 22, 2018.

Surrey man found guilty of second degree murder in partner Rama Gauravarapu's death

Drug coverage approved in B.C. for those with ALS

Drug coverage approved in B.C. for those with ALS
British Columbia's Health Ministry has negotiated an agreement with a manufacturer to allow for coverage of a drug used to slow the symptoms of ALS or Lou Gehrig's disease.

Drug coverage approved in B.C. for those with ALS